FGL1 and neoplasm: further demonstrated that FGL1 can inhibit the activity and growth effect of T cells and disrupt the interaction between FGL1 and LAG-3 through genetic ablation or monoclonal antibody blockage to significantly improve T cell responses and promote anti-tumor immunity (15).